検索タンパク質、抗体、アッセイキット
タンパク質カタログ
輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。
- サプライヤー
- TargteMol
- カタログNo.
- TMPY-03645
- 製品名称
- BAFF/TNFSF13B Protein, Cynomolgus, Recombinant (hFc)
- タンパク質名
- BAFF/TNFSF13B
- Species
- Cynomolgus
- HOST
- HEK293 Cells
- 100μg: -
- お問い合わせ
Overview
| Synonyms | tumor necrosis factor (ligand) superfamily, member 13b |
|---|---|
| Characteristics | 1. Immobilized Cynomolgus Fc-TNFSF13B at 10 μg/ml (100 μl/well) can bind biotinylated Cynomolgus TNFRSF17-Fc , the EC50 of biotinylated Cynomolgus TNFRSF17-Fc is 4.5-10.5 ng/ml. 2. Measured in a cell proliferation assay using mouse splenocytes. The ED50 for this effect is typically 1-6 ng/mL. |
| Endotoxin Level | < 1.0 EU/μg of the protein as determined by the LAL method. |
| Purity | 96.30% |
| Description | BAFF/TNFSF13B Protein, Cynomolgus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 38.1 kDa and the accession number is F7H548. |
| Reference | Nardelli B,et al.(2002) B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseases. Leuk Lymphoma. 43(7): 1367-73.,Stohl W. (2006) Therapeutic targeting of B lymphocyte stimulator (BLyS) in the rheumatic diseases. Endocr Metab Immune Disord Drug Targets. 6(4): 51-8.,Cancro MP,et al.(2009) The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus. J Clin Invest. 119(5): 1066-73. |
| URL | https://www.targetmol.com/recombinant-protein/baff_blys_protein_cynomolgus_recombinant_hfc_tag_ |
お問い合わせリスト